"Then, as it’s done in the past, the company pivoted to a post-hoc analysis, picking out a subset of younger patients to show where their treatment had an effect. Even then, the results only approached but did not reach statistical significance."
"... did not reach statistical significance". Nope. Don't see a correlation. A lot of data coming from our trials do not seem to echo that.
Tread carefully mums/dads/newbies and DYOR.A lot of misinformation out there from poster are tickling the taint of unlicensed advise.
Just sayin'. With words.
Cell Therapy News/Articles, page-13548
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.015(1.36%) |
Mkt cap ! $1.278B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.10 | $7.169M | 6.411M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7296 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 43068 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |